Barbara Bierer, MD
Barbara’s affiliation with Tullis began when she served with Jim Tullis on the board of directors of ViaCell, a former Tullis portfolio company. Barbara joined the Tullis advisory board in 2004 and later became a domain partner. With her wealth of clinical, research, and scientific knowledge, Barbara participates in deal sourcing, deal review, due diligence, and investment management.
A hematologist-oncologist, Barbara is Professor of Medicine at Harvard Medical School and the Brigham and Women’s Hospital (BWH). She co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a collaborative effort to improve standards for the planning and conduct of international clinical trials with a particular focus in emerging economies. In this capacity, she works with regulators around the world, major pharmaceutical companies, biotech, clinical research organizations, academia and patients/patient advocates to harmonize policies for and approaches to clinical trial regulation. In 2017, the MRCT Center launched the non-profit organization Vivli, a global clinical research data sharing platform. In addition, she is the Director of the Regulatory Foundations, Ethics, and the Law program at the Harvard Catalyst, the Harvard Clinical and Translational Science Award, working across the academic spectrum to enable the clinical trial enterprise from study planning through recruitment to data acquisition and dissemination. Barbara is the Director of Regulatory Policy for SMART IRB, a national effort to align single-site IRB review of multi-site trials. From 2003 – 2014, she served as Senior Vice President, Research at the Brigham and Women’s Hospital, during which time she founded and served as Executive Sponsor of the Brigham Research Institute and the Brigham Innovation Hub (iHub), a focus for entrepreneurship and innovation in healthcare. She has authored over 210 publications.
In addition to her academic responsibilities, Barbara served as Chair of the Secretary’s Advisory Committee for Human Research Protections, HHS and as a member of the National Academies of Sciences Committee on Science, Technology and the Law. She currently serves on the Board of Directors of Management Sciences for Health (MSH), Clinithink, and Vivli; chairs the Board of Trustees of the Edward P. Evans Foundation; and sits on the Scientific Advisory Board for Molecular Stethoscope, Inc.
Barbara received a BS from Yale University and an MD from Harvard Medical School.
Where It Counts
Speaking Engagements Over 25 Years
Countries Visited in a Professional Capacity
Original Articles Authored